| |
In manufacturing biological products, there is risk of virus contamination at many levels, from raw materials to processing. This contamination risk means virus testing is required. A proper testing program is essential to ensure the biological product achieves the fastest time to market. By working with a qualified contract laboratory, the best testing strategy can be executed to assure product safety.
In this white paper, Merribeth Morin, Ph.D, Director of Virology at Microtest, reviews the potential sources of contamination, cell bank characterization (virus safety), virus concerns during manufacturing, and ways to effectively partner with a contract testing laboratory.
Download the free white paper, “Virus Testing for Biological Products: Partnering With a Contract Lab,” by clicking on the link below.
Microtest offers a complete range of pharmaceutical and virology test services. These services can support full in-process and product release testing as well as product stability testing, raw material qualification and assay development/validation.
As a growing provider of fill/finish operations, Microtest has all the systems and procedures in place to fully support all the requirements of the FDA, EMEA and any drug-regulating body in the world. With a problem-solving approach, customer service focus, and technical expertise, Microtest has the ability to help pharmaceutical companies reduce costs and risk, support rapid regulatory approvals, and enjoy reliable, fast, turn-arounds.
For more information, contact Microtest on the Web via the link below, or toll-free at: 1-800-631-1680.
About Microtest
Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, biotechnology industries. Based in Agawam, Massachusetts, USA, the company's expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption.
|
bgerrish[.]tizinc.com 
